M Pharmaceutical Inc. announced that its Board of Directors has made a decision to open a fully owned subsidiary company M Pharma Bulgaria Ltd. with a clear mandate to achieve registration of the Company's temporary controllable pseudobezoar technology Trimeo as a medical device in the European Union, and to obtain a CE Mark for it. M Pharma Bulgaria will collaborate with Medica AD (Bulgaria), a leading producer of CE certified medical materials in Eastern Europe, and with local vendors to achieve these objectives.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | +9,900.00% | -.--% | +9,900.00% |
2018 | James Thompson to Assume the Position of President and Chief Executive Officer of Callitas Health Inc | CI |
2018 | Callitas Health Inc. Announces Management Changes | CI |
1st Jan change | Capi. | |
---|---|---|
+9,900.00% | 4.53K | |
+23.50% | 47.07B | |
+47.64% | 42.06B | |
-5.16% | 39.98B | |
+36.37% | 33.02B | |
-7.79% | 27.9B | |
+18.06% | 27.63B | |
+47.29% | 14.37B | |
+41.91% | 13.45B | |
-1.02% | 12.03B |
- Stock Market
- Equities
- MPHMF Stock
- News Callitas Health Inc.
- M Pharmaceutical Inc. to Open a Fully Owned Subsidiary in Sofia, Bulgaria